z-logo
open-access-imgOpen Access
Sevoflurane Preconditioning Attenuates Myocardial Ischemia/Reperfusion Injury via Caveolin-3–Dependent Cyclooxygenase-2 Inhibition
Author(s) -
Jianli Zhao,
Feng Wang,
Yanqing Zhang,
Liyuan Jiao,
Wayne Bond Lau,
Lili Wang,
Baojiang Liu,
Erhe Gao,
Walter J. Koch,
Xinliang Ma,
Yajing Wang
Publication year - 2013
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.112.000045
Subject(s) - cardioprotection , medicine , ampk , sevoflurane , caveolin 3 , reperfusion injury , cyclooxygenase , knockout mouse , ischemia , caveolin 1 , nicotinamide adenine dinucleotide phosphate , pharmacology , endocrinology , autophagy , protein kinase a , apoptosis , kinase , signal transduction , caveolae , oxidase test , chemistry , biochemistry , enzyme , receptor
The inhaled anesthetic sevoflurane has been demonstrated to protect against myocardial ischemia/reperfusion (MI/R) injury via mechanisms involving AMP-activated protein kinase (AMPK) and caveolin-3 (Cav-3). However, the relative contributions of AMPK and Cav-3 to sevoflurane preconditioning (SF-PreCon)-mediated cardioprotection and their precise underlying mechanisms of action remain incompletely understood.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom